Molecularly targeted cancer therapy: some lessons from the past decade.
about
Maintaining Tumor Heterogeneity in Patient-Derived Tumor XenograftsFluorescent imaging of cancerous tissues for targeted surgery.Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and TreatmentExploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationSmall-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse ChemotherapeuticsThe challenges of tumor genetic diversity.COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo.The role of the Hippo pathway in human disease and tumorigenesisCorrelative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupThe Repurposing Drugs in Oncology (ReDO) Project.Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targetsBioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerHomologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test.Repurposing medicinal compounds for blood cancer treatment.Derivation of a fifteen gene prognostic panel for six cancers.CASTIN: a system for comprehensive analysis of cancer-stromal interactome.Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine.Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression data.Predictive Modeling of Drug Treatment in the Area of Personalized Medicine.Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types.Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma.LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation.On-Demand Targeting: Investigating Biology with Proximity-Directed Chemistry.DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitroBruceine D induces apoptosis in human chronic myeloid leukemia K562 cells via mitochondrial pathway.Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer modelsIntegrative analysis of cancer genes in a functional interactome.FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell CarcinomaIntegrating precision cancer medicine into healthcare-policy, practice, and research challenges.A METHYLATION-TO-EXPRESSION FEATURE MODEL FOR GENERATING ACCURATE PROGNOSTIC RISK SCORES AND IDENTIFYING DISEASE TARGETS IN CLEAR CELL KIDNEY CANCER.Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer.Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells.Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.Translational research in oncology--10 years of progress and future prospects.Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls.Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.Reprogramming the oncogenic response: SET protein as a potential therapeutic target in cancer.Small Molecules for Active Targeting in Cancer.Profiling lung adenocarcinoma by liquid biopsy: can one size fit all?
P2860
Q26801063-7A21F20A-523F-4509-B4EF-6A3DA7CACCC8Q26830905-251C3860-565D-4398-B222-8FA746BE90B7Q28076462-2CD0721A-47B5-42A3-A3A8-6FA35C1DDB3BQ28118450-64FF5D40-0318-4342-9BB1-A0B9E24F0E72Q29027136-A663C046-1BDC-4950-9E1A-825D13F1A4A2Q30241056-FB4C516D-FBB5-4BD7-8364-92531A9F6516Q30367429-AB78DF9A-C9F6-4133-B2A4-840627094366Q30433413-9703BD51-A5F9-4D52-B12B-810D7B596EA8Q33587905-65803B0A-4173-441C-877C-95FD1C447735Q33893949-E1B31758-6C39-421D-95BA-81C8D0B84BEFQ33903831-293AEF55-7F5C-4F47-9DDD-87B63176426DQ34295621-A680AB79-B371-4416-9933-C2F27CFF52C5Q35752069-4901EDFD-33CE-45C3-90D6-8E1C205E3CABQ35807959-E1113C98-D93A-4940-9F34-2DDF1E3143B9Q35953479-BBDE1E75-4B4C-486F-BCB0-885F70DF23E9Q36187726-4E8BE4E2-60F2-4367-BB0B-8D4B732B1F00Q36303802-32D9C726-C6EC-45E7-8C89-BD8C38EF1391Q36309864-E16FEBC5-6C39-42C3-AD69-13D289175DE3Q36351777-39C080D8-32FF-4CA6-8D08-92BD7BE3CB48Q36534662-CAC9C011-91FB-4A3B-A5D6-A877FEAA682DQ36557486-169FF78F-62E8-4F7F-A89D-11F4C4C0158AQ36629339-5798FEE8-7890-46FD-9AA9-E3F498B4B7C4Q36723089-B44FF2F9-487B-486D-8E9D-ED975DC59A96Q36746141-A2AD717D-B799-495C-9F88-1C287995AAFEQ36879500-F33517FF-3075-4D7B-9A29-5C964D0F32C6Q37013417-52D9958F-1F6E-4D3E-A6EB-3BA9F907BFCFQ37054427-0692402C-B915-4274-8C03-D96AE3DC1906Q37067161-0B606B0E-2DE3-46DB-99FB-F63E50E2F2EDQ37360550-D040EC79-76CC-48BF-BBD8-72F75A0952BBQ37526339-F23D8ED8-7E5A-4B42-9B98-A89E7E936849Q37699384-D418B7A3-3E4F-47BF-A1B2-5BB41C8DBEC4Q37706287-DBF5E8BD-5F67-4EC3-A9FF-9CD3DCBA4E1AQ37708902-9081160D-765F-437F-B1CB-05F78C47D9A3Q38257126-F1D22485-D5E8-45AE-A09B-7BC6FE66BCE6Q38263008-0EDCB5B9-E839-4169-9538-7FC09569F961Q38271490-6B75D5F7-B28D-4820-8D57-F836E5FAB917Q38617369-F87A1A13-BE53-41CF-81E8-2774F1A29811Q38678579-98562E8D-EF2D-4E14-8A8E-CBBAFD9B1944Q38780383-BA6DE004-4011-4F06-B9A4-7A2C442BF292Q38785389-310A7E0F-E722-4985-9E56-CBC2C7BFE7B9
P2860
Molecularly targeted cancer therapy: some lessons from the past decade.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecularly targeted cancer therapy: some lessons from the past decade.
@en
type
label
Molecularly targeted cancer therapy: some lessons from the past decade.
@en
prefLabel
Molecularly targeted cancer therapy: some lessons from the past decade.
@en
P2093
P1476
Molecularly targeted cancer therapy: some lessons from the past decade.
@en
P2093
P356
10.1016/J.TIPS.2013.11.004
P577
2013-12-19T00:00:00Z